Results 121 to 130 of about 12,078 (208)

Further clinical and pharmacokinetic observations on the new anticonvulsant, oxcarbazepine.

open access: yes, 1988
Continuing experience with oxcarbazepine has shown that the drug tends to be less sedative than carbamazepine and at least as potent as an anticonvulsant but much more likely to cause hyponatraemia.
Dickinson R.G.   +4 more
core  

Efficacy and safety of oxcarbazepine in the treatment of children with epilepsy: a meta-analysis of randomized controlled trials

open access: yesNeuropsychiatric Disease and Treatment, 2017
Hua Geng, Chengzhong Wang Department of Pediatrics, Maternal and Child Health Hospital of Yancheng, Yancheng City, People’s Republic of China Background: To assess the efficacy and safety of oxcarbazepine (OXC) in the treatment of children with ...
Geng H, Wang CZ
doaj  

Serum sodium changes in children with focal epilepsy receiving carbamazepine or oxcarbazepine therapy: a randomized controlled trial

open access: yes
Background: Carbamazepine and oxcarbazepine are commonly used antiseizure medications for focal epilepsy in children. Both drugs may alter serum sodium, but comparative pediatric data, particularly from South Asian settings, remain limited. The objective
A. B. M. Mukib   +4 more
core   +1 more source

Home - About - Disclaimer - Privacy